United States · FDA National Drug Code directory
IRINOTECAN HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55150-352_2fc24d11-bf17-4007-8a65-d949793a972e
- Product NDC
- 55150-352
- Form
- INJECTION, SOLUTION
- Composition / generic term
- IRINOTECAN HYDROCHLORIDE
- Labeler
- Eugia US LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200211
- Source listing expiry
- 20261231
Source-listed ingredients
- IRINOTECAN HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-352-01) / 2 mL in 1 VIAL, SINGLE-DOSE · 55150-352-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →